loadpatents
Patent applications and USPTO patent grants for Payton; Lori.The latest application filed is for "dosage and administration of anti-c5 antibodies for treatment of atypical hemolytic uremic syndrome (ahus)".
Patent | Date |
---|---|
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Atypical Hemolytic Uremic Syndrome (ahus) App 20220235121 - Payton; Lori ;   et al. | 2022-07-28 |
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) IN PEDIATRIC PATIENTS App 20210332147 - PAYTON; Lori ;   et al. | 2021-10-28 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Paroxysmal Nocturnal Hemoglobinuria (pnh) In Pediatric Patients App 20210214425 - PAYTON; Lori ;   et al. | 2021-07-15 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Paroxysmal Nocturnal Hemoglobinuria (pnh) And Atypical Hemolyti App 20200254092 - Kind Code | 2020-08-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.